Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes.
Gerstein HC, Sattar N, Rosenstock J, Ramasundarahettige C, Pratley R, Lopes RD, Lam CSP, Khurmi NS, Heenan L, Del Prato S, Dyal L, Branch K; AMPLITUDE-O Trial Investigators. Gerstein HC, et al. N Engl J Med. 2021 Sep 2;385(10):896-907. doi: 10.1056/NEJMoa2108269. Epub 2021 Jun 28. N Engl J Med. 2021. PMID: 34215025 Free article. Clinical Trial.
The role of endogenous GIP and GLP-1 in postprandial bone homeostasis.
Helsted MM, Gasbjerg LS, Lanng AR, Bergmann NC, Stensen S, Hartmann B, Christensen MB, Holst JJ, Vilsbøll T, Rosenkilde MM, Knop FK. Helsted MM, et al. Among authors: stensen s. Bone. 2020 Nov;140:115553. doi: 10.1016/j.bone.2020.115553. Epub 2020 Jul 27. Bone. 2020. PMID: 32730920 Clinical Trial.
The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes.
Dalsgaard NB, Gasbjerg LS, Hansen LS, Hansen NL, Stensen S, Hartmann B, Rehfeld JF, Holst JJ, Vilsbøll T, Knop FK. Dalsgaard NB, et al. Among authors: stensen s. Eur J Endocrinol. 2021 Mar;184(3):383-394. doi: 10.1530/EJE-20-1121. Eur J Endocrinol. 2021. PMID: 33449919 Clinical Trial.
The naturally occurring GIP(1-30)NH2 is a GIP receptor agonist in humans.
Krogh LSL, Henriksen K, Stensen S, Skov-Jeppesen K, Bergmann NC, Størling J, Rosenkilde MM, Hartmann B, Holst JJ, Gasbjerg LS, Knop FK. Krogh LSL, et al. Among authors: stensen s. Eur J Endocrinol. 2023 Jan 10;188(1):lvac015. doi: 10.1093/ejendo/lvac015. Eur J Endocrinol. 2023. PMID: 36651162
Acute concomitant glucose-dependent insulinotropic polypeptide receptor antagonism during glucagon-like peptide 1 receptor agonism does not affect appetite, resting energy expenditure or food intake in patients with type 2 diabetes and overweight/obesity.
Stensen S, Krogh LL, Sparre-Ulrich AH, Dela F, Hartmann B, Vilsbøll T, Holst JJ, Rosenkilde MM, Christensen MB, Gasbjerg LS, Knop FK. Stensen S, et al. Diabetes Obes Metab. 2022 Sep;24(9):1882-1887. doi: 10.1111/dom.14736. Epub 2022 Jun 20. Diabetes Obes Metab. 2022. PMID: 35491518 No abstract available.
16 results